Overview
Jan Storek practices in Canada. Storek is rated as an Advanced expert by MediFind in the treatment of Scleroderma. Their top areas of expertise are Graft Versus Host Disease (GvHD), Mononucleosis, Scleroderma, Neuromyelitis Optica, and Bone Marrow Transplant.
Their clinical research consists of co-authoring 101 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 11 articles in the study of Scleroderma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Graft Versus Host Disease (GvHD)Storek isDistinguished. Learn about Graft Versus Host Disease (GvHD).
- Advanced
- Bone Marrow TransplantStorek isAdvanced. Learn about Bone Marrow Transplant.
- MononucleosisStorek isAdvanced. Learn about Mononucleosis.
- Neuromyelitis OpticaStorek isAdvanced. Learn about Neuromyelitis Optica.
- Optic NeuritisStorek isAdvanced. Learn about Optic Neuritis.
- SclerodermaStorek isAdvanced. Learn about Scleroderma.
- Systemic Sclerosis (SSc)Storek isAdvanced. Learn about Systemic Sclerosis (SSc).
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)Storek isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Aplastic AnemiaStorek isExperienced. Learn about Aplastic Anemia.
- ChickenpoxStorek isExperienced. Learn about Chickenpox.
- Chronic Graft Versus Host Disease (cGvHD)
- Chronic Myelogenous Leukemia (CML)